Vimarsana
Biggest News Aggregation in the World

Jackpharma Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jackpharma Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jackpharma Inc Today - Breaking & Trending Today

Anti-viral pill lacks EUA, SRP can't be issued yet: DOH - Vimarsana News

Anti-viral pill lacks EUA, SRP can't be issued yet: DOH

Published: October 29, 2021

Molnupiravir (Photo courtesy of Merck & Co.) MANILA - The yet-to-be-approved anti-viral pill molnupiravir still lacks emergency use authorization and no suggested retail price can be issued since it is still under study by regulators, a health official said Friday. In an online media forum, Department of Health (DOH) Undersecretary Maria Rosario Vergeire noted that only four hospitals had been granted compassionate special permit (CSP)to administer the pill that is deemed to cut the risk of hospitalization for adults with mild to moderate symptoms of the coronavirus disease 2019 (Covid-19)...

Source: philippinetimes.com
Related Topics:
Aurobindo PharmaMeneleo HernandezMonaliza Balnig SalianMaria Rosario VergeireDepartment Of HealthMerck CoJackpharma IncUndersecretary Maria Rosario VergeireClinical Practice GuidelinesMolnupiravir Photo Courtesy Of Merck Amp Co Manila The Yet To Be Approved Anti Viral Pill Still Lacks Emergency Use Authorization And No Suggested Retail Price Can Issued Since It Is Under Study By RegulatorsA Health Official Said Friday In An Online Media ForumEpartment Of Health Doh Undersecretary Maria Rosario Vergeire Noted That Only Four Hospitals Had Been Granted Compassionate Special Permit Csp To Administer The Pill Is Deemed Cut Risk Hospitalization For Adults With Mild Moderate Symptoms Coronavirus Disease 2019 Covid 19 Physicians And Using Molnupiravir Under Are Accountable Its Outcome On Patients Quot Having SaidIndi Pa Rin Tayo Pwede Makapag Issue Ng Srp Suggested Retail Price Kasi Pinag Aaralan Ito We Cannot Suggest An Because It Is Still Under Study Uot Vergeire Said Quot Kelangan Lumabas Muna Ito Sa Living Cpg Guidelines Clinical Practice Ng Doh Para Marekomenda At Magkaroon Srp Ang Isang Gamot This Has To Be Included In The 39s So It Could Recommended And Have An Read Compassionate Permit For Molnupiravir Granted 4 Hospitals Fda Since Only Hasa CspHe Government Cannot Havea Tripartite Agreement With Any EntityHe Said Quot Hindi Pa Natin Ito Pwede Ipagbili Ngo Bumili Tayo Ng Pangmalawakan Dahil Wala Po Siyang Authorization To Be Used We Cannot Sell It Yet Or Purchase In Large Amounts Because Does Not Have The Uot Vergeire Said Molnupiravir Was Developed By Merck Amp Co Hich Said It Is Likely To Be Effective Against All Known Coronavirus Variants As Does Not Target The Spike Protein Of Virus That Differentiates Comes Ina 200 Mg Capsule Witha Recommended Regimen 800 Taken Twice Daily For Five Days Or Prescribed By Doctor During An Online Press Conference On WednesdayOcal Importer Medethix Co Founder Monaliza Balnig Salian Said The Initial Delivery Of Molnupiravir Would Cover About 300000 Patients Salian Said It Was Found Out That 81 Percent Of The 1200 Mild Cases Taking Molnupiravir Had Negative Reverse Transcription Polymerase Chain Reaction Rt Pcr Results On The Fifth Day Of Treatment In Clinical Trials Sponsored By Merck Licensee Aurobindo Pharma India MeanwhileNc President Meneleo Hernandez Said The Market Price Of Molnupiravir Quot Will Be Established In Early November And It Quite Affordable Estimated At Php100 To Php130 Per Pill Pna
Filipinos may get Merck's anti-viral pill early - Vimarsana News

Filipinos may get Merck's anti-viral pill early

Published: October 28, 2021

COVID-19 patients in the Philippines may get early access to Merck & Co.’s yet to be approved anti-viral treatment pill starting in November.

Source: thestar.com.my
Related Topics:
Monaliza SalianMeny Hernandez JrMedethix IncMerck CoJackpharma IncIndia Aurobindo Pharma LtdAurobindo Pharma LtdMedethix Chief Executive Officer Monaliza Salian
Merck strikes global pill deal - Vimarsana News

Merck strikes global pill deal

Published: October 28, 2021

US drugmaker Merck & Co on October 27 announced a deal that could see generic versions of its Covid-19 medication widely distributed in poorer countries, in a first during the pandemic.

Source: phnompenhpost.com
Related Topics:
United StatesMonaliza SalianEric DomingoWendy HolmanCharles GoreHerve VerhooselRidgeback BiotherapeuticsMeneleo Hernandez JrDrug AdministrationMerck Co OnJackpharma IncWorld Health OrganisationMedicines Patent PoolDoctors Without BordersPhilippine Daily
Anti-Covid pill shipment to arrive in November - Vimarsana News

Anti-Covid pill shipment to arrive in November

Published: October 27, 2021

Anti-Covid pill shipment to arrive in November

Source: sunstar.com.ph
Related Topics:
Metro ManilaPhilippines GeneralMonaliza SalianMeny HernandezAurobindo PharmaEmory UniversityMedethix IncDrug AdministrationJackpharma IncMarites Villamor IlanoSunstar Philippines
Anti-COVID-19 pill molnupiravir to arrive in PH in November - Vimarsana News

Anti-COVID-19 pill molnupiravir to arrive in PH in November

Published: October 27, 2021

The first oral coronavirus disease (COVID-19) antiviral drug, Molnupiravir, will be available in the country next month, local importer MedEthix announced on Wednesday, Oct. 27. Screenshot from MedEthix's press conference on Tuesday, Oct. 27 (HANDOUT/ MANILA BULLETIN) During a press conference,

Source: mb.com.ph
Related Topics:
Aurobindo PharmaMeneleo HernandezMonaliza Balnig SalianDrug AdministrationJackpharma IncCompassionate Special PermitPresident Meneleo Hernandez